Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MMX Mesalamine Maintenance in Ulcerative Colitis
NCT01124149Phase 4Completed
- Sponsor
- Takeda
- Start
- Jun 2010
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 15
01
Overview
Phase 4, open-label, single-arm trial of Salcrozine in ulcerative colitis (UC), sponsored by Takeda. Primary endpoint: Percentage of Subjects in Complete Remission at Month 12 of Maintenance Phase. Started Jun 2010; status: completed.
02
Drugs
Salcrozine
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT01124149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01124149.